Contribution of Ultrasonography in the Evaluation of Cervical

Clinical Trial Summary

Study of the contribution of ultrasound measurements of the uterine cervix related to the calculation of Bishop score. Evaluation of the period between cervical induction and delivery. Study of ultrasound data to improve the care of these patients requiring induction.

Clinical Trial Description

n/a

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention

See also
Status	Clinical Trial	Phase
Completed	`NCT01765881` - Comparison Between 25 µg Vaginal Misoprostol vs Slow Release Pessary PGE2	Phase 2
Recruiting	`NCT01506102` - Thromboelastography During and After Delivery	N/A
Completed	`NCT02655783` - Use of Normal Saline With or Without Dextrose During Induction of Labor in Nulliparous	N/A
Recruiting	`NCT01505192` - Noninvasive Continuous Measurement of SpHb After Spontaneous Vaginal Delivery	N/A

See also

Status

Clinical Trial

Phase

Completed

NCT01765881 - Comparison Between 25 µg Vaginal Misoprostol vs Slow Release Pessary PGE2

Phase 2

Recruiting

NCT01506102 - Thromboelastography During and After Delivery

N/A

Completed

NCT02655783 - Use of Normal Saline With or Without Dextrose During Induction of Labor in Nulliparous

N/A

Recruiting

NCT01505192 - Noninvasive Continuous Measurement of SpHb After Spontaneous Vaginal Delivery

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT02570620
Study type	Interventional
Source	University Hospital, Tours
Contact
Status	Completed
Phase	N/A
Start date	September 2010
Completion date	March 2014

Contribution of Ultrasonography in the Evaluation of Cervical Induction-delivery Time — ECOLDIA

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms